bio-k8凯发
we have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
explore further
we are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs
we have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
explore further
guangzhou, china– june 2 , 2024 – bio-thera solutions inc. (688177:sh), a commercial-stage biopharmaceutical companydeveloping a pipeline of innovative therapies and biosimilars, will present apost...
bio-theraand stada h ave reached an exclusive commercialization and license agreement forbat2506, a biosimilar candidate to simponi ? (golimumab) bio-thera will maintain responsibility fordevelopment,...
